Two complementary predictors (DAAE-M and ELIE) estimate individualized 5-year progression risk using routine clinical data, extending the prior DAAE framework beyond static baseline risk. Registry ...
Companies aim to improve drug discovery by training AI on one another’s data and generating large, open datasets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results